Literature DB >> 32815025

Testosterone serum levels are not predictive of maternal virilization in hyperreactio luteinalis.

Mateja Condic1, Waltraut M Merz2, Ulrich Gembruch2, Dietrich Klingmüller3, Birgit Stoffel-Wagner4, Ramona Dolscheid-Pommerich4.   

Abstract

BACKGROUND: Elevated concentrations of circulating testosterone are present in hyperreactio luteinalis (HL), a pregnancy-specific, self-limited condition. HL is associated with maternal virilization in about 30% of cases. The correlation between testosterone levels and maternal virilization has not yet been quantified. Our aim was to identify a testosterone cut-off level which may allow to predict maternal virilization.
METHODS: A literature research was performed. Publications were chosen if serum testosterone concentrations and presence or absence of maternal virilization was mentioned. Additionally, we report serial levels of steroids analyzed by Liquid chromatography-tandem mass spectrometry (LC-MS/MS) in one case of HL managed at our institution.
RESULTS: In all, 31 cases fulfilled the search criteria. We found significant overlap between testosterone levels in asymptomatic women and women with signs of virilization (range 6.2-37.3 nmol/l and 13.7-197.5 nmol/l, respectively). The method applied for testosterone analysis was mentioned in three reports only. Peak serum testosterone concentration in our case was 120.3 nmol/l.
CONCLUSION: From the available data, maternal virilization in HL cannot be predicted by the level of circulating testosterone. However, comparability of results is hampered by the analytical methods applied. LC-MS/MS should preferably be used for reporting concentrations of circulating testosterone.

Entities:  

Keywords:  Electrochemiluminescence immunoassay; Hyperandrogenism; Hyperreactio luteinalis; Liquid chromatography–tandem mass spectrometry; Maternal virilization; Pregnancy-associated virilization

Mesh:

Substances:

Year:  2020        PMID: 32815025      PMCID: PMC7854420          DOI: 10.1007/s00404-020-05745-6

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  43 in total

1.  Hyperreactio luteinalis presenting with marked hyperglycemia and bilateral multicystic adnexal masses at 21 weeks gestation.

Authors:  David M Sherer; Mudar Dalloul; Fady Khoury-Collado; Mira Hellman; Joseph A Osho; Roopa S P Gupta; Ovadia Abulafia
Journal:  Am J Perinatol       Date:  2006-02       Impact factor: 1.862

2.  Hyperreactio luteinalis in pregnancy.

Authors:  Christian Amoah; Ahmed Yassin; Eimear Cockayne; Alice Bird
Journal:  Fertil Steril       Date:  2011-04-16       Impact factor: 7.329

3.  A case of recurrent hyperreactio luteinalis.

Authors:  Narumi Onodera; Ikuko Kishi; Yukoku Tamaoka; Kazuto Yamazaki; Kiyoshi Kamei
Journal:  Am J Obstet Gynecol       Date:  2008-03-14       Impact factor: 8.661

4.  Hyperreactio luteinalis with clitoromegaly in a twin pregnancy.

Authors:  Sarah M Page; Jennie O'Brien
Journal:  Rev Obstet Gynecol       Date:  2009

5.  Hyperreactio luteinalis in normal singleton pregnancy.

Authors:  M Okadome; T Kaku; N Tsukamoto; T Saito; K Matsukuma; K Uehira; T Hirakawa; H Nakano
Journal:  Int J Gynaecol Obstet       Date:  1989-08       Impact factor: 3.561

6.  Hyperreactio luteinalis despite the absence of a corpus luteum and suppressed serum follicle stimulating concentrations in a triplet pregnancy.

Authors:  J H Check; J K Choe; A Nazari
Journal:  Hum Reprod       Date:  2000-05       Impact factor: 6.918

Review 7.  Gestational Hyperandrogenism in Developmental Programming.

Authors:  Christopher Hakim; Vasantha Padmanabhan; Arpita K Vyas
Journal:  Endocrinology       Date:  2017-02-01       Impact factor: 4.736

8.  Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome.

Authors:  Helge Binder; Ralf Dittrich; Ina Hager; Andreas Müller; Sonja Oeser; Matthias W Beckmann; Miklos Hamori; Peter A Fasching; Reiner Strick
Journal:  Reproduction       Date:  2008-01       Impact factor: 3.906

9.  Clinical cure of severe, early onset preeclampsia with low molecular weight heparin therapy in primigravida with hyperreactio luteinalis and thrombophilia.

Authors:  Terhi Saisto; Aila Tiitinen; Veli-Matti Ulander; Risto Kaaja
Journal:  Hum Reprod       Date:  2004-01-29       Impact factor: 6.918

10.  Delayed lactogenesis II: a comparison of four cases.

Authors:  Christine M Betzold; Kathleen L Hoover; Cathy L Snyder
Journal:  J Midwifery Womens Health       Date:  2004 Mar-Apr       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.